Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 43
Filtrar
3.
Emerg Infect Dis ; 22(12): 2174-2177, 2016 12.
Artículo en Inglés | MEDLINE | ID: mdl-27869601

RESUMEN

We detected orthopoxvirus in 28 of 125 serum samples collected during 2009 from cattle in Uruguay. Two samples were PCR-positive for vaccinia virus and had sequences similar to those for vaccinia virus associated with outbreaks in Brazil. Autochthonous circulation of vaccinia virus in Uruguay and other South American countries cannot be ruled out.


Asunto(s)
Enfermedades de los Bovinos/epidemiología , Enfermedades de los Bovinos/virología , Virus Vaccinia/genética , Vaccinia/veterinaria , Animales , Bovinos , Brotes de Enfermedades , Genes Virales , Geografía Médica , ARN Viral , América del Sur/epidemiología , Uruguay/epidemiología , Virus Vaccinia/clasificación , Virus Vaccinia/aislamiento & purificación , Zoonosis
4.
Virol J ; 13: 121, 2016 07 04.
Artículo en Inglés | MEDLINE | ID: mdl-27377374

RESUMEN

BACKGROUND: Bovine vaccinia (BV) is a zoonosis caused by Vaccinia virus, a virus from Orthopoxvirus genus (OPV) that affects mainly cattle herds and humans in rural areas in Brazil. Because most studies have focused on outbreaks situations, data on BV epidemiology is limited. A cross sectional study in Brazilian rural areas during 2012-2013 was conducted to determine the neutralizing antibodies seroprevalence and risk factors for BV. METHODS: A structured questionnaire was applied to elicit demographics data and farming practices considered risk factors for BV exposure. Neutralizing anti-OPV antibodies were investigated using plaque reduction neutralization test. The neutralizing antibodies prevalence rates were calculated and the risk factor analysis was performed using multivariate logistic regression. RESULTS: Two hundred and forty participants were enrolled in this study with a prevalence of neutralizing antibodies of 30.8 % (95 % confidence interval [CI], 25.3-36.9). In multivariate analysis, age > 35 years (Odds Ratio [OR] = 18.2; CI 95 % = 7.7 - 43.2) and previous outbreak in property (OR = 3.9; C I95 % = 1.2 - 12.6) were independently associated with anti-OPV neutralizing antibodies. CONCLUSIONS: In this study, anti-OPV protective immunity (neutralizing antibody titers) was assessed in an endemic BV Brazilian rural area. Our findings indicate that epidemiological surveillance is required and should be applied by public health authorities to create interventions and/or prevention strategies to avoid viral spread causing future outbreaks among individuals who are under risk of infection.


Asunto(s)
Anticuerpos Antivirales/sangre , Orthopoxvirus/inmunología , Infecciones por Poxviridae/sangre , Zoonosis/sangre , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Enfermedades de los Trabajadores Agrícolas/sangre , Enfermedades de los Trabajadores Agrícolas/inmunología , Enfermedades de los Trabajadores Agrícolas/virología , Animales , Anticuerpos Neutralizantes/sangre , Brasil/epidemiología , Niño , Preescolar , Estudios Transversales , Femenino , Humanos , Ganado/virología , Masculino , Persona de Mediana Edad , Orthopoxvirus/genética , Orthopoxvirus/aislamiento & purificación , Infecciones por Poxviridae/inmunología , Infecciones por Poxviridae/virología , Población Rural , Estudios Seroepidemiológicos , Adulto Joven , Zoonosis/epidemiología , Zoonosis/inmunología , Zoonosis/virología
5.
Artículo en Inglés | MEDLINE | ID: mdl-27260805

RESUMEN

In Brazil, serologic evidence of Orthopoxvirus (OPV) circulation showed positivity around 20% in cattle, humans, monkeys and rodents. Although OPV seropositivity has been described in buffalo herds in southeastern Brazil, no Vaccinia virus (VACV) (member of genus OPV) outbreaks in buffalo herds have been described in this country. This study aimed to investigate the detection of anti-OPV antibodies and to study the OPV genome in Brazilian buffalo herds. Our results demonstrated a high OPV seropositivity in buffalo herds on Marajó Island and molecular data confirmed the circulation of VACV. The geographical isolation conditionmight be a sine qua non condition to explain our results.


Asunto(s)
Anticuerpos Antivirales/sangre , Búfalos/virología , Orthopoxvirus/inmunología , Infecciones por Poxviridae/veterinaria , Virus Vaccinia/inmunología , Virus Vaccinia/aislamiento & purificación , Vaccinia/veterinaria , Animales , Brasil/epidemiología , Brotes de Enfermedades/veterinaria , Geografía , Orthopoxvirus/genética , Orthopoxvirus/aislamiento & purificación , Filogenia , Infecciones por Poxviridae/virología , Alineación de Secuencia , Estudios Seroepidemiológicos , Vaccinia/epidemiología , Vaccinia/virología , Zoonosis
6.
Rev Soc Bras Med Trop ; 49(1): 125-9, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27163577

RESUMEN

A case of dengue virus 3 (DENV-3) genotype I infection with neurological manifestations occurred in Belo Horizonte, Minas Gerais in October 2012. The serotype was detected by PCR, and the genotype was assessed by sequencing and phylogenetic analysis of the C-prM region. The virus causing neurological manifestations clustered with other sequences of DENV-3 genotype I. Because neurological manifestations of DENV are possibly misdiagnosed in Brazil, this study serves as an alert of the importance of DENV diagnoses in CNS infections.


Asunto(s)
Enfermedades Virales del Sistema Nervioso Central/virología , Virus del Dengue/genética , Dengue/virología , Enfermedades Virales del Sistema Nervioso Central/complicaciones , Dengue/complicaciones , Femenino , Genotipo , Humanos , Filogenia , ARN Viral/genética , Adulto Joven
7.
Rev. Soc. Bras. Med. Trop ; 49(1): 125-129, Jan.-Feb. 2016. graf
Artículo en Inglés | LILACS | ID: lil-776529

RESUMEN

Abstract: A case of dengue virus 3 (DENV-3) genotype I infection with neurological manifestations occurred in Belo Horizonte, Minas Gerais in October 2012. The serotype was detected by PCR, and the genotype was assessed by sequencing and phylogenetic analysis of the C-prM region. The virus causing neurological manifestations clustered with other sequences of DENV-3 genotype I. Because neurological manifestations of DENV are possibly misdiagnosed in Brazil, this study serves as an alert of the importance of DENV diagnoses in CNS infections.


Asunto(s)
Humanos , Femenino , Adulto Joven , Enfermedades Virales del Sistema Nervioso Central/virología , Dengue/virología , Virus del Dengue/genética , Filogenia , ARN Viral/genética , Enfermedades Virales del Sistema Nervioso Central/complicaciones , Dengue/complicaciones , Genotipo
8.
Mem Inst Oswaldo Cruz ; 110(6): 804-8, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26517662

RESUMEN

Vaccinia virus naturally circulates in Brazil and is the causative agent of a zoonotic disease known as bovine vaccinia (BV). We retrospectively evaluated two populations from the Amazon and Southeast Regions. BV outbreaks had not been reported in these regions before sample collection. Neutralising antibodies were found in 13 individuals (n = 132) with titres ranging from 100 ≥ 6,400 neutralising units/mL. Univariate analysis identified age and vaccination as statistically significant risk factors in individuals from the Southeast Region. The absence of detectable antibodies in vaccinated individuals raises questions about the protection of smallpox vaccine years after vaccination and reinforces the need for surveillance of Orthopoxvirus in Brazilian populations without evidence of previous outbreaks.


Asunto(s)
Anticuerpos Antivirales/aislamiento & purificación , Orthopoxvirus/inmunología , Población Rural , Vaccinia/prevención & control , Adolescente , Adulto , Factores de Edad , Anciano , Animales , Anticuerpos Neutralizantes , Anticuerpos Antivirales/sangre , Brasil/epidemiología , Bovinos , Niño , Preescolar , Brotes de Enfermedades , Monitoreo Epidemiológico , Femenino , Humanos , Masculino , Vacunación Masiva , Persona de Mediana Edad , Estudios Retrospectivos , Factores de Riesgo , Vaccinia/epidemiología , Virus Vaccinia/inmunología , Adulto Joven , Zoonosis/epidemiología
9.
PLoS One ; 10(4): e0123531, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25856570

RESUMEN

RAP1 (RAS proximate 1), a small GTP-binding protein of the RAS superfamily, is a putative oncogene that is highly expressed in several malignant cell lines and types of cancers, including some types of squamous cell carcinoma. However, the participation of RAP1 in cervical carcinogenesis is unknown. We conducted a cross-sectional study of paraffin-embedded cervical biopsies to determine the association of RAP1 with cervical intraepithelial neoplasia (CIN). Standard and quantitative immunohistochemistry assessment of RAP1 expression in fixed tissue was performed on 183 paraffin-embedded cervical biopsies that were classified as normal or non-dysplastic mucosa (NDM) (n = 33); CIN grade 1 (n = 84) and CIN grade 2/3 (n = 66). A gradual increase in RAP1 expression in NDM < CIN 1 < CIN 2/3 (p<0.001) specimens was observed and was in agreement with the histopathologic diagnosis. A progressive increase in the RAP1 expression levels increased the risk of CIN 1 [odds ratio (OR) = 3.50; 95% confidence interval (CI) 1.30-10.64] 3.5 fold and the risk of CIN 2/3 (OR = 19.86, 95% CI 6.40-70.79) nearly 20 fold when compared to NDM. In addition, stereotype ordinal regression analysis showed that this progressive increase in RAP1 expression more strongly impacted CIN 2/3 than CIN 1. Our findings suggest that RAP1 may be a useful biomarker for the diagnosis of CIN.


Asunto(s)
Biomarcadores de Tumor/biosíntesis , Carcinoma de Células Escamosas/genética , Proteínas de Unión a Telómeros/biosíntesis , Displasia del Cuello del Útero/genética , Adolescente , Adulto , Anciano , Biomarcadores de Tumor/genética , Carcinogénesis/genética , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/patología , Femenino , Regulación Neoplásica de la Expresión Génica , Humanos , Persona de Mediana Edad , Estadificación de Neoplasias , Factores de Riesgo , Complejo Shelterina , Proteínas de Unión a Telómeros/genética , Displasia del Cuello del Útero/diagnóstico , Displasia del Cuello del Útero/patología
10.
Emerg Infect Dis ; 21(4): 695-8, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25811411

RESUMEN

In 2010, a vaccinia virus isolate caused an atypically severe outbreak that affected humans and cattle in Brazil. Of 26 rural workers affected, 12 were hospitalized. Our data raise questions about the risk factors related to the increasing number and severity of vaccinia virus infections.


Asunto(s)
Enfermedades de los Bovinos/epidemiología , Virus Vaccinia , Vaccinia/epidemiología , Zoonosis/epidemiología , Adolescente , Adulto , Animales , Brasil/epidemiología , Bovinos , Enfermedades de los Bovinos/virología , Brotes de Enfermedades , Genes Virales , Humanos , Persona de Mediana Edad , Filogenia , Vaccinia/virología , Virus Vaccinia/clasificación , Virus Vaccinia/genética , Virus Vaccinia/aislamiento & purificación , Adulto Joven , Zoonosis/virología
12.
Arch Virol ; 159(10): 2621-32, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24862187

RESUMEN

Oxidative stress is a disturbance in the oxidant-antioxidant balance leading to potential cellular damage. Most cells can tolerate a mild degree of oxidative stress because they have a system that counteracts oxidation that includes antioxidant molecules such as glutathione (GSH) and superoxide dismutase (SOD). Disruption of the host antioxidant status has been recognized as an important contributor to the pathogenesis of many viruses. Caraparu virus (CARV) is a member of group C of the Bunyaviridae family of viruses. In South American countries, group C bunyaviruses are among the common agents of human febrile illness and have caused multiple notable outbreaks of human disease in recent decades; nevertheless, little is known about the pathogenic characteristics of these viruses. The purpose of this study was to examine the hepatic pathogenesis of CARV in mice and the involvement of oxidative stress and antioxidant defenses on this pathology. Following subcutaneous infection of BALB/c mice, CARV was detected in the liver, and histopathology revealed acute hepatitis. Increased serum levels of aspartate and alanine aminotransferases (AST/ALT) and greater hepatic expression of the proinflammatory cytokine tumor necrosis factor-α (TNF-α) were found in infected animals. CARV infection did not alter the biomarkers of oxidative stress but caused an increase in GSH content and altered the expression and activity of SOD. This is the first report of an alteration of oxidative homeostasis upon CARV infection, which may, in part, explain the hepatic pathogenesis of this virus, as well as the pathogenesis of other Bunyaviridae members.


Asunto(s)
Infecciones por Bunyaviridae/patología , Hígado/patología , Orthobunyavirus/patogenicidad , Estrés Oxidativo , Alanina Transaminasa/sangre , Animales , Aspartato Aminotransferasas/sangre , Glutatión/biosíntesis , Hepatitis/virología , Hígado/virología , Ratones , Ratones Endogámicos BALB C , Orthobunyavirus/clasificación , Especies Reactivas de Oxígeno , Superóxido Dismutasa/biosíntesis , Factor de Necrosis Tumoral alfa/biosíntesis , Replicación Viral
13.
Autoimmunity ; 47(2): 119-26, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24328427

RESUMEN

2'5'OAS are template-independent RNA polymerases with antiviral activity and important to homeostasis maintenance. Here we have developed quantitative PCR (qPCR) reactions for the detection of each individual 2'5'OAS human gene and used them to evaluate these gene levels in systemic sclerosis patients cells. The method was efficient for quantification of 2'5'OAS genes on human cells after interferon (IFN) treatment, and revealed that primary cells from patients with systemic sclerosis have increased basal levels of OASL and OAS2 genes. When treated, patients cells are able to induce all four 2'5'OAS genes. Our hypothesis is that abnormally circulating type I IFNs on the disease could be establishing a desensitized state on patients cells, making them refractory to subsequent IFN doses, and that OASL and OAS2 genes upregulation may be due to an IFN-independent stimulus. Further characterizing the biological activities of these genes, their induction pathways and their regulatory functions can lead to better understanding of systemic sclerosis molecular mechanisms and of their biological activities.


Asunto(s)
2',5'-Oligoadenilato Sintetasa/genética , Leucocitos Mononucleares/inmunología , Reacción en Cadena de la Polimerasa/métodos , Esclerodermia Sistémica/genética , 2',5'-Oligoadenilato Sintetasa/inmunología , Adulto , Anciano , Línea Celular Tumoral , Femenino , Expresión Génica , Humanos , Interferón-alfa/farmacología , Interferón beta/farmacología , Isoenzimas/genética , Isoenzimas/inmunología , Leucocitos Mononucleares/efectos de los fármacos , Leucocitos Mononucleares/patología , Masculino , Persona de Mediana Edad , Especificidad de Órganos , Cultivo Primario de Células , Esclerodermia Sistémica/inmunología , Esclerodermia Sistémica/patología , Regulación hacia Arriba
14.
Am J Trop Med Hyg ; 89(6): 1142-5, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24166043

RESUMEN

In Brazil, several exanthematic autochthone Vaccinia virus (VACV) outbreaks affecting dairy cattle and rural workers have been reported since 1999. Although outbreaks had been first described in the Brazilian Southeast, VACV outbreaks were notified in all Brazilian regions in < 10 years. However, in this context, VACV outbreaks had not been described in some Brazilian States, likely because of a lack of notification, or yet unknown epidemiological reasons. Here, we describe the first VACV outbreak in Maranhão State, northeastern Brazil. The virus isolated from this outbreak showed several biological and molecular features that resemble other Group 1 Brazilian VACV, including a deletion signature in the A56R gene. This study raises new questions about diversity and epidemiology of Brazilian VACV.


Asunto(s)
Enfermedades de los Bovinos/epidemiología , Brotes de Enfermedades , Virus Vaccinia/aislamiento & purificación , Vaccinia/epidemiología , Animales , Secuencia de Bases , Brasil/epidemiología , Bovinos , Enfermedades de los Bovinos/virología , Eliminación de Gen , Variación Genética , Datos de Secuencia Molecular , Filogenia , Alineación de Secuencia , Análisis de Secuencia de ADN , Vaccinia/virología , Virus Vaccinia/genética , Proteínas Virales/genética , Zoonosis
15.
Mem Inst Oswaldo Cruz ; 108(5): 554-62, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23903969

RESUMEN

Interfering with cellular signal transduction pathways is a common strategy used by many viruses to create a propitious intracellular environment for an efficient replication. Our group has been studying cellular signalling pathways activated by the orthopoxviruses Vaccinia (VACV) and Cowpox (CPXV) and their significance to viral replication. In the present study our aim was to investigate whether the GTPase Rac1 was an upstream signal that led to the activation of MEK/ERK1/2, JNK1/2 or Akt pathways upon VACV or CPXV' infections. Therefore, we generated stable murine fibroblasts exhibiting negative dominance to Rac1-N17 to evaluate viral growth and the phosphorylation status of ERK1/2, JNK1/2 and Akt. Our results demonstrated that VACV replication, but not CPXV, was affected in dominant-negative (DN) Rac1-N17 cell lines in which viral yield was reduced in about 10-fold. Viral late gene expression, but not early, was also reduced. Furthermore, our data showed that Akt phosphorylation was diminished upon VACV infection in DN Rac1-N17 cells, suggesting that Rac1 participates in the phosphoinositide-3 kinase pathway leading to the activation of Akt. In conclusion, our results indicate that while Rac1 indeed plays a role in VACV biology, perhaps another GTPase may be involved in CPXV replication.


Asunto(s)
Virus de la Viruela Vacuna/fisiología , Sistema de Señalización de MAP Quinasas/fisiología , Transducción de Señal/fisiología , Virus Vaccinia/fisiología , Replicación Viral/fisiología , Proteína de Unión al GTP rac1/fisiología , Animales , Células 3T3 BALB , Chlorocebus aethiops , Ratones , Fosforilación/fisiología , Células Vero , Proteína de Unión al GTP rac1/metabolismo
16.
Mem. Inst. Oswaldo Cruz ; 108(5): 554-562, ago. 2013. graf
Artículo en Inglés | LILACS | ID: lil-680770

RESUMEN

Interfering with cellular signal transduction pathways is a common strategy used by many viruses to create a propitious intracellular environment for an efficient replication. Our group has been studying cellular signalling pathways activated by the orthopoxviruses Vaccinia (VACV) and Cowpox (CPXV) and their significance to viral replication. In the present study our aim was to investigate whether the GTPase Rac1 was an upstream signal that led to the activation of MEK/ERK1/2, JNK1/2 or Akt pathways upon VACV or CPXV' infections. Therefore, we generated stable murine fibroblasts exhibiting negative dominance to Rac1-N17 to evaluate viral growth and the phosphorylation status of ERK1/2, JNK1/2 and Akt. Our results demonstrated that VACV replication, but not CPXV, was affected in dominant-negative (DN) Rac1-N17 cell lines in which viral yield was reduced in about 10-fold. Viral late gene expression, but not early, was also reduced. Furthermore, our data showed that Akt phosphorylation was diminished upon VACV infection in DN Rac1-N17 cells, suggesting that Rac1 participates in the phosphoinositide-3 kinase pathway leading to the activation of Akt. In conclusion, our results indicate that while Rac1 indeed plays a role in VACV biology, perhaps another GTPase may be involved in CPXV replication.


Asunto(s)
Animales , Ratones , Virus de la Viruela Vacuna/fisiología , Sistema de Señalización de MAP Quinasas/fisiología , Transducción de Señal/fisiología , Virus Vaccinia/fisiología , Replicación Viral/fisiología , Proteína de Unión al GTP rac1/fisiología , Chlorocebus aethiops , Fosforilación/fisiología , Células Vero , Proteína de Unión al GTP rac1/metabolismo
17.
J Virol Methods ; 187(1): 114-20, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23018061

RESUMEN

Dengue virus (DENV) is the most prevalent arbovirus in the world, found mainly in tropical regions. As clinical manifestations present frequently as nonspecific febrile illness, laboratory diagnosis is essential to confirm DENV infections and for epidemiological studies. Recombinant envelope (E) antigens of four serotypes of DENV were used to develop an immunoglobulin G enzyme-linked immunosorbent assay (IgG-ELISA). To evaluate the IgG-ELISA, a panel of serum samples that had been tested previously by a plaque reduction neutralization test (PRNT) was investigated for the presence of anti-E antibodies against the four DENV serotypes. IgG-ELISA was found to have a sensitivity (91%) and specificity (98%) at a receiver-operating characteristic (ROC) optimized cutoff and demonstrated high performance as well as good indexes. A concordance of 97% was achieved between both assays, and only 21/704 (3%) samples were not concordant. The results of the present study demonstrate a moderate correlation between neutralizing antibody titers and IgG-ELISA values. These findings indicate that the recombinant protein-based IgG-ELISA is a suitable method for routine serodiagnosis, monitoring and seroepidemiological studies of DENV infections.


Asunto(s)
Anticuerpos Antivirales/sangre , Virus del Dengue/inmunología , Dengue/diagnóstico , Ensayo de Inmunoadsorción Enzimática , Proteínas del Envoltorio Viral/inmunología , Anticuerpos Neutralizantes/sangre , Anticuerpos Antivirales/inmunología , Antígenos Virales/inmunología , Dengue/inmunología , Dengue/virología , Virus del Dengue/clasificación , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina G/inmunología , Pruebas de Neutralización , Proteínas Recombinantes/inmunología , Sensibilidad y Especificidad , Estudios Seroepidemiológicos , Pruebas Serológicas
18.
Emerg Infect Dis ; 18(12): 2035-8, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23171598

RESUMEN

In 2011, vaccinia virus caused an outbreak of bovine vaccinia, affecting dairy cattle and dairy workers in Brazil. Genetic and phenotypic analyses identified this isolate as distinct from others recently identified, thereby reinforcing the hypothesis that different vaccinia virus strains co-circulate in Brazil.


Asunto(s)
Enfermedades de los Bovinos/epidemiología , Enfermedades de los Bovinos/virología , Brotes de Enfermedades/veterinaria , Virus Vaccinia/aislamiento & purificación , Vaccinia/veterinaria , Animales , Brasil/epidemiología , Bovinos , Línea Celular , Hemaglutininas Virales/genética , Humanos , Ratones , Filogenia , Vaccinia/epidemiología , Vaccinia/virología , Virus Vaccinia/clasificación , Virus Vaccinia/genética
19.
J Clin Virol ; 55(4): 323-8, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22947947

RESUMEN

BACKGROUND: Acanthamoeba polyphaga mimivirus (APMV), the largest known virus, has been studied as a putative pneumonia agent, especially in hospital environments. Despite the repercussions of the discovery of APMV, there has been no study related to the control of APMV and the susceptibility of this virus to disinfectants. OBJECTIVES: This work investigated the virucidal activity against mimivirus of chemical biocides commonly used in clinical practice for the disinfection of hospital equipment and rooms. STUDY DESIGN: APMV was dried on sterilized steel coupons, exposed to different concentrations of alcohols (ethanol, 1-propanol and 2-propanol) and commercial disinfectants (active chlorine, glutaraldehyde and benzalkonium chloride) and titrated in amoebas using the TCID50 value. The stability of APMV on an inanimate surface was also tested in the presence and absence of organic matter for 30 days. RESULTS: APMV showed a high level of resistance to chemical biocides, especially alcohols. Only active chlorine and glutaraldehyde were able to decrease the APMV titers to undetectable levels. Dried APMV showed long-lasting stability on an inanimate surface (30 days), even in the absence of organic matter. CONCLUSIONS: The data presented herein may help health and laboratory workers plan the best strategy to control this putative pneumonia agent from surfaces and devices.


Asunto(s)
Desinfectantes/farmacología , Viabilidad Microbiana/efectos de los fármacos , Mimiviridae/efectos de los fármacos , Mimiviridae/fisiología , Humanos , Pruebas de Sensibilidad Microbiana
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA